Matinas Biopharma Holdings Shares Outstanding 2012-2018 | MTNB

Matinas Biopharma Holdings shares outstanding from 2012 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Matinas Biopharma Holdings Annual Shares Outstanding
(Millions of Shares)
2017 90
2016 58
2015 51
2014 32
2013 19
2012 10
2011 0
Matinas Biopharma Holdings Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 95
Q2 2018 94
Q1 2018 94
Q4 2017 90
Q3 2017 92
Q2 2017 92
Q1 2017 85
Q4 2016 58
Q3 2016 58
Q2 2016 58
Q1 2016 57
Q4 2015 51
Q3 2015 57
Q2 2015 56
Q1 2015 36
Q4 2014 32
Q3 2014 32
Q2 2014 32
Q1 2014 32
Q4 2013 19
Q3 2013 15
Q2 2013 10
Q1 2013 10
Q4 2012 0
Q3 2012 0
Q4 2011 0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.118B $0.000B
Matinas BioPharma is a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its LNC platform technology. The Company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic and orally bioavailable. The Company's lead anti-fungal product candidate, MAT2203, utilizes its proprietary lipid nano-crystal formulation technology for the safe and effective delivery of the broad-spectrum fungicidal agent, amphotericin B. Based on the positive patient clinical data reported in 2017, Matinas is preparing for a potential Phase 2 pivotal trial of MAT2203 for prevention of invasive fungal infections in patients with acute lymphoblastic leukemia.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $45.821B 30.37
Takeda Pharmaceutical (TAK) Japan $31.966B 11.83
Grifols (GRFS) Spain $13.614B 16.50
Ionis Pharmaceuticals (IONS) United States $8.114B 0.00
Neurocrine Biosciences (NBIX) United States $7.658B 496.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.596B 10.90
Sage Therapeutics (SAGE) United States $7.546B 0.00
Nektar Therapeutics (NKTR) United States $7.216B 10.34
Loxo Oncology (LOXO) United States $7.184B 0.00
Tilray (TLRY) United States $7.126B 0.00
Catalent (CTLT) United States $6.121B 25.63
United Therapeutics (UTHR) United States $5.214B 8.53
FibroGen (FGEN) United States $4.971B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.146B 13.34
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.102B 21.81
USANA Health Sciences (USNA) United States $2.519B 20.56
Endo (ENDP) Ireland $2.371B 3.63
Ironwood Pharmaceuticals (IRWD) United States $2.342B 0.00
Heron Therapeutics (HRTX) United States $2.155B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.082B 0.00
Portola Pharmaceuticals (PTLA) United States $2.057B 0.00
Xencor (XNCR) United States $2.050B 0.00
Enanta Pharmaceuticals (ENTA) United States $2.005B 24.98
Zogenix (ZGNX) United States $1.972B 0.00
Aerie Pharmaceuticals (AERI) United States $1.898B 0.00
PTC Therapeutics (PTCT) United States $1.701B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.688B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.673B 226.00
Theravance Biopharma (TBPH) Cayman Islands $1.527B 0.00
Corcept Therapeutics (CORT) United States $1.363B 20.00
TherapeuticsMD (TXMD) United States $1.344B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.252B 0.00
Esperion Therapeutics (ESPR) United States $1.221B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.987B 0.00
Tricida (TCDA) United States $0.971B 0.00
ImmunoGen (IMGN) United States $0.842B 0.00
Radius Health (RDUS) United States $0.833B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.591B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.565B 0.00
Siga Technologies (SIGA) United States $0.562B 0.00
Karyopharm Therapeutics (KPTI) United States $0.559B 0.00
Flexion Therapeutics (FLXN) United States $0.555B 0.00
ChemoCentryx (CCXI) United States $0.554B 43.84
BioSpecifics Technologies Corp (BSTC) United States $0.521B 30.74
GlycoMimetics (GLYC) United States $0.513B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.512B 0.00
Collegium Pharmaceutical (COLL) United States $0.492B 0.00
Forty Seven (FTSV) United States $0.481B 0.00
Odonate Therapeutics (ODT) United States $0.443B 0.00
Aptorum Group (APM) China $0.431B 0.00
Translate Bio (TBIO) United States $0.422B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.400B 0.00
Lannett Co Inc (LCI) United States $0.386B 3.58
Akebia Therapeutics (AKBA) United States $0.379B 0.00
ArQule (ARQL) United States $0.372B 0.00
KalVista Pharmaceuticals (KALV) United States $0.368B 0.00
Concert Pharmaceuticals (CNCE) United States $0.352B 0.00
CASI Pharmaceuticals (CASI) United States $0.343B 0.00
Tyme Technologies (TYME) United States $0.330B 0.00
Dermira (DERM) United States $0.327B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.327B 0.00
Majesco Entertainment (PTE) United States $0.311B 0.00
OptiNose (OPTN) United States $0.305B 0.00
Aclaris Therapeutics (ACRS) United States $0.304B 0.00
Minerva Neurosciences (NERV) United States $0.297B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.285B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.281B 10.48
MARKER THERAPEUTICS, INC (MRKR) United States $0.246B 0.00
Mast Therapeutics (SVRA) United States $0.241B 0.00
Opexa Therapeutics (ACER) United States $0.231B 0.00
IMV INC (IMV) Canada $0.225B 0.00
Dova Pharmaceuticals (DOVA) United States $0.223B 0.00
MEI Pharma (MEIP) United States $0.216B 0.00
Aratana Therapeutics (PETX) United States $0.215B 0.00
Affimed (AFMD) Germany $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.211B 0.00
Rafael Holdings (RFL) United States $0.208B 0.00
Calithera Biosciences (CALA) United States $0.204B 0.00
Aldeyra Therapeutics (ALDX) United States $0.204B 0.00
Xeris Pharmaceuticals (XERS) United States $0.203B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.198B 0.00
ElectroCore (ECOR) United States $0.195B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.195B 0.00
Recro Pharma (REPH) United States $0.186B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.180B 0.00
Redhill Biopharma (RDHL) Israel $0.179B 0.00
Molecular Templates (MTEM) United States $0.171B 0.00
Aquestive Therapeutics (AQST) United States $0.166B 0.00
Zafgen (ZFGN) United States $0.165B 0.00
Nature's Sunshine Products (NATR) United States $0.164B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.163B 0.00
Ardelyx (ARDX) United States $0.162B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.155B 0.00
Ocular Therapeutix (OCUL) United States $0.151B 0.00
Adherex Technologies (FENC) United States $0.151B 0.00
AgeX Therapeutics (AGE) United States $0.150B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.148B 0.00
Neon Therapeutics (NTGN) United States $0.140B 0.00
Jounce Therapeutics (JNCE) United States $0.138B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.137B 0.00
Cardiome Pharma (CORV) Canada $0.134B 0.00
MediWound (MDWD) Israel $0.128B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.122B 0.00
DURECT (DRRX) United States $0.120B 0.00
China SXT Pharmaceuticals (SXTC) China $0.118B 0.00
ProNAi Therapeutics (SRRA) Canada $0.118B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.103B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.086B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.085B 0.00
Iterum Therapeutics (ITRM) Ireland $0.081B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.081B 0.00
Natural Alternatives (NAII) United States $0.080B 7.82
Nivalis Therapeutics (ALPN) United States $0.080B 0.00
Infinity Pharmaceuticals (INFI) United States $0.079B 0.00
Melinta Therapeutics (MLNT) United States $0.077B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.077B 0.00
Neos Therapeutics (NEOS) United States $0.071B 0.00
Immune Design (IMDZ) United States $0.069B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.069B 0.00
SCYNEXIS (SCYX) United States $0.066B 0.00
Forward Pharma (FWP) Denmark $0.065B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.065B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.063B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.063B 0.00
Avenue Therapeutics (ATXI) United States $0.062B 0.00
Otonomy (OTIC) United States $0.062B 0.00
KemPharm (KMPH) United States $0.061B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.059B 0.00
CTI BioPharma (CTIC) United States $0.055B 0.00
Mannatechorporated (MTEX) United States $0.046B 0.00
BioLineRx (BLRX) Israel $0.043B 0.00
Genocea Biosciences (GNCA) United States $0.043B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.042B 0.00
Achaogen (AKAO) United States $0.042B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.041B 0.00
Lipocine (LPCN) United States $0.036B 0.00
Capnia (SLNO) United States $0.036B 0.00
ContraFect (CFRX) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Heat Biologics (HTBX) United States $0.034B 0.00
NOVAN INC (NOVN) United States $0.031B 0.00
NanoViricides (NNVC) United States $0.027B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.026B 0.00
PharmAthene (ALT) United States $0.026B 0.00
IsoRay (ISR) United States $0.026B 0.00
Biomerica (BMRA) United States $0.024B 0.00
ESSA Pharma (EPIX) Canada $0.023B 0.00
Can-Fite Biopharma (CANF) Israel $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Xenetic Biosciences (XBIO) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.019B 0.00
Onconova Therapeutics (ONTX) United States $0.019B 0.00
HANCOCK JAFFE (HJLI) United States $0.019B 0.00
Trillium Therapeutics (TRIL) Canada $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.017B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.017B 0.00
Jaguar Animal Health (JAGX) United States $0.016B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.014B 0.00
VAXART, INC (VXRT) United States $0.014B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.011B 0.00
Shineco (TYHT) China $0.011B 1.19
DelMar Pharmaceuticals (DMPI) Canada $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.009B 0.00
Intellipharmaceutics (IPCI) Canada $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.001B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00